MeVis Medical Solutions AG announced group earnings results for the year 2013. The group revenues generated in 2013 amounted to EUR 14.6 million, up 10% compared to the previous year's revenues of EUR 13.3 million. The increase in licensing business by 11% from EUR 6.9 million to EUR 7.7 million as well as an increase in non-recurring engineering contrbutions of EUR 0.5 million to EUR 1.0 million contributed to this growth. Maintenance revenues remained stable at EUR 5.9 million. The increase in revenues resulted almost entirely from the Digital Mammography segment, where revenues rose from EUR 10.1 million to EUR 11.3 million, while revenues in the Other Diagnostics segment rose only marginally from EUR 3.2 million to EUR 3.3 million. For 2013 this results in an EBIT (earnings before interest and taxes) of EUR 4.0 million, which is EUR 1.0 million higher than previous year and corresponds to an EBIT margin of 27% (previous year: 21%).

For 2014, the expects revenues between EUR 12.0 million and EUR 12.5 million. This is a slight decrease compared to the extremely positive year 2013, for which, on a comparable basis, revenues of EUR 12.8 million would have been reported. The company expects an EBIT of between EUR 3.0 million and EUR 3.5 million, which is lower than the adjusted previous year's figure of EUR 4.4 million due to the slight decline in revenues and a selective increase of resources for development and sales.